MG149 Inhibits MOF-Mediated p53 Acetylation to Attenuate X-Ray Radiation-Induced Apoptosis in H9c2 Cells

Qianwen Nie1,2, Xuan Huan1,2, Jing Kang1,2

  • 1Lanzhou University Second College of Clinical Medicine, Chengguan District, Lanzhou 730030, China.

Radiation Research
|December 9, 2022
PubMed

Insights

Males absent on the first (MOF) epigenetically regulates p53K120 acetylation, mediating X-ray radiation-induced cardiomyocyte apoptosis. Inhibiting MOF with MG149 protects against radiation injury by attenuating this epigenetic mechanism.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cardiovascular Research

Background:

  • Cardiomyocyte apoptosis contributes to radiation-induced heart disease.
  • The specific epigenetic mechanisms driving this process are not fully understood.

Purpose of the Study:

  • To investigate the role of males absent on the first (MOF) in X-ray radiation-induced cardiomyocyte apoptosis.
  • To explore the potential of MOF inhibition as a therapeutic strategy.

Main Methods:

  • H9c2 cells were irradiated with 4 Gy X-rays.
  • Cells were pretreated with the MOF inhibitor MG149.
  • Assessed cell proliferation, injury, apoptosis, mitochondrial membrane potential, and reactive oxygen species (ROS) production.

Main Results:

  • X-ray radiation upregulated MOF expression in H9c2 cells.
  • MG149 treatment suppressed radiation-induced proliferation inhibition, mitochondrial dysfunction, ROS production, and apoptosis.
  • MG149 inhibited MOF-mediated p53K120 acetylation.

Conclusions:

  • MOF plays a mediating role in X-ray radiation-induced cardiomyocyte apoptosis via p53K120 acetylation.
  • MOF inhibition presents a potential therapeutic approach to mitigate radiation-induced heart injury.